Usana Health Sciences (USNA) Invested Capital (2014 - 2026)

Usana Health Sciences (USNA) has reported Invested Capital for 7 consecutive years, with $14.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Invested Capital fell 39.13% year-over-year to $14.0 million; the TTM figure through Apr 2026 stood at $28.0 million (down 39.13% YoY), while the FY2026 annual figure was $14.0 million, down 39.13% from the prior year.
• Invested Capital steadied at $14.0 million in Q2 2026 per USNA's latest filing, from $14.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $23.0 million in Q4 2024 and bottomed at $786000.0 in Q4 2023.
• Historically, Invested Capital has averaged $12.3 million across 5 years, with a median of $14.0 million in 2026.
• Annual changes were most pronounced in 2024 — Invested Capital jumped 2826.21% — and 2026, when it plunged 39.13%.
• Usana Health Sciences' Invested Capital stood at $10.0 million in 2022, then sank by 92.14% to $786000.0 in 2023, then soared by 2826.21% to $23.0 million in 2024, then changed by 0.0% to $23.0 million in 2025, then sank by 39.13% to $14.0 million in 2026.
• Business Quant data shows USNA's Invested Capital at $14.0 million in Q2 2026, $14.0 million in Q1 2026, and $23.0 million in Q1 2025.